Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cocrystal Pharma Inc COCP

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function... see more

Recent & Breaking News (NDAQ:COCP)

Detailed Research: Economic Perspectives on Cocrystal Pharma, Genius Brands International, Gemphire Therapeutics, Global Water Resources, Infrastructure and Energy Alternatives, and Condor Hospitality Trust — What Drives Growth in Today's Competitive Land

GlobeNewswire November 19, 2018

CLASS ACTION UPDATE for COCP, JT and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire November 18, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, ABBV, CHGG, HON and DY

GlobeNewswire November 16, 2018

COCP DEADLINE NOTICE ALERT: Rosen Law Firm Reminds Cocrystal Pharma, Inc. Investors of Important Nov. 19 Deadline in First Filed Case – COCP

GlobeNewswire November 16, 2018

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Cocrystal Pharma, Inc. To Contact The Firm

GlobeNewswire November 15, 2018

DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire November 15, 2018

SHAREHOLDER ALERT: APOG COCP COST TRVN HON DY ALGN AQUA SONS TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire November 14, 2018

Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Microchip Technology Inc. 

GlobeNewswire November 13, 2018

CLASS ACTION UPDATE for MCHP, COCP and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire November 13, 2018

Cocrystal Pharma Announces Presentation of Preclinical Characterization Data of CC-42344 at the 6th ISIRV-AVG Conference

GlobeNewswire November 13, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of USAT, COCP, TRVN, HTHT and SFIX

GlobeNewswire November 13, 2018

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Cocrystal Pharma, Inc., formerly known as BioZone Pharmaceuticals, Inc. (COCP) and November 19 Lead Plaintiff Deadline

Business Wire November 13, 2018

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Chegg, Hasbro, and Campbell Soup and Encourages Investors to Contact the Firm

GlobeNewswire November 12, 2018

SHAREHOLDER ALERT: APOG COCP ABBV COST HTHT SFIX CWH OZK NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire November 12, 2018

Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update

GlobeNewswire November 12, 2018

CLASS ACTION UPDATE for MCHP, COCP and HTHT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire November 11, 2018

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire November 10, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ryanair Holdings plc - RYAAY

Canada NewsWire November 9, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRCO, CPB, DY, IGC and FIT

GlobeNewswire November 8, 2018

SHAREHOLDER ALERT: MCHP COCP ABBV JT TRVN SFIX CWH HON ALGN NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire November 8, 2018